{"id":"https://openalex.org/W3110249225","doi":"https://doi.org/10.1182/bloodadvances.2020002970","title":"Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden.","display_name":"Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden.","publication_year":2020,"publication_date":"2020-12-08","ids":{"openalex":"https://openalex.org/W3110249225","doi":"https://doi.org/10.1182/bloodadvances.2020002970","mag":"3110249225","pmid":"https://pubmed.ncbi.nlm.nih.gov/33275766","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7724916"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7724916","doi":"https://doi.org/10.1182/bloodadvances.2020002970","is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7724916","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7724916","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085185312","display_name":"Douglas A. Tremblay","orcid":"https://orcid.org/0000-0002-4719-7192","observed_orcids":["https://orcid.org/0000-0002-4719-7192","https://orcid.org/0000-0003-2584-6953"]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Tremblay","raw_affiliation_strings":["Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I45438204","display_name":"The University of Texas at San Antonio","ror":"https://ror.org/01kd65564","country_code":"US","type":"education","lineage":["https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben Mesa","raw_affiliation_strings":["Mays Cancer Center, University of Texas, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mays Cancer Center, University of Texas, San Antonio, TX","institution_ids":["https://openalex.org/I4390039360","https://openalex.org/I45438204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart Scott","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103255098","display_name":"Sarah A. Buckley","orcid":"https://orcid.org/0000-0002-7041-8328","observed_orcids":["https://orcid.org/0000-0002-7041-8328"]},"institutions":[{"id":"https://openalex.org/I4210101701","display_name":"CTI BioPharma (United States)","ror":"https://ror.org/017bk0e71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Buckley","raw_affiliation_strings":["CTI Biopharma Corporation, Seattle, WA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CTI Biopharma Corporation, Seattle, WA; and","institution_ids":["https://openalex.org/I4210101701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013310470","display_name":"Karisse Roman\u2010Torres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101701","display_name":"CTI BioPharma (United States)","ror":"https://ror.org/017bk0e71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karisse Roman-Torres","raw_affiliation_strings":["CTI Biopharma Corporation, Seattle, WA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CTI Biopharma Corporation, Seattle, WA; and","institution_ids":["https://openalex.org/I4210101701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085521139","display_name":"Sr\u0111an Verstov\u0161ek","orcid":"https://orcid.org/0000-0002-6912-8569","observed_orcids":["https://orcid.org/0000-0002-6912-8569"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srdan Verstovsek","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072336042","display_name":"John O Mascarenhas","orcid":"https://orcid.org/0000-0002-8400-0483","observed_orcids":["https://orcid.org/0000-0002-8400-0483"]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Mascarenhas","raw_affiliation_strings":["Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.941,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.86712794,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"4","issue":"23","first_page":"5929","last_page":"5935"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pacritinib","display_name":"pacritinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/spleen-volume-reduction","display_name":"spleen volume reduction","score":0.8320000171661377},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.8399999737739563},{"id":"https://openalex.org/keywords/symptom-burden","display_name":"symptom burden","score":0.6650000214576721},{"id":"https://openalex.org/keywords/best-available-therapy","display_name":"best available therapy","score":0.8339999914169312}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.7590352892875671},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.7287564277648926},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7133653163909912},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.6997964382171631},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6599538922309875},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.5660353899002075},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5308238863945007},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.49566829204559326},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3679163157939911},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1534707248210907},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.11615628004074097},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10884559154510498},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:7724916","doi":"https://doi.org/10.1182/bloodadvances.2020002970","is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7724916","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:33275766","doi":"https://doi.org/10.1182/bloodadvances.2020002970","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33275766","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"},{"id":"mag:3110249225","doi":"https://doi.org/10.1182/bloodadvances.2020002970","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33275766","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7724916","doi":"https://doi.org/10.1182/bloodadvances.2020002970","is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7724916","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1980568348","https://openalex.org/W2005582645","https://openalex.org/W2014268597","https://openalex.org/W2015662674","https://openalex.org/W2016466834","https://openalex.org/W2018317651","https://openalex.org/W2063756127","https://openalex.org/W2084050646","https://openalex.org/W2115351357","https://openalex.org/W2121743767","https://openalex.org/W2123633897","https://openalex.org/W2146505525","https://openalex.org/W2157694607","https://openalex.org/W2289879004","https://openalex.org/W2514287253","https://openalex.org/W2554963629","https://openalex.org/W2598479043","https://openalex.org/W2771403719","https://openalex.org/W2791240656","https://openalex.org/W2896385413","https://openalex.org/W2973011755","https://openalex.org/W3007570521","https://openalex.org/W3008023739","https://openalex.org/W3034783567"],"related_works":["https://openalex.org/W2983287333","https://openalex.org/W4379282483","https://openalex.org/W4386071127","https://openalex.org/W2029985592","https://openalex.org/W4386282152","https://openalex.org/W2791240656","https://openalex.org/W2591579771","https://openalex.org/W2945289622","https://openalex.org/W1941147162","https://openalex.org/W2805747764"],"abstract_inverted_index":{"Myelofibrosis":[0],"(MF)":[1],"has":[2],"heterogeneous":[3],"clinical":[4],"manifestations,":[5],"with":[6,44,61,98,115,145,199,224,228,244],"some":[7],"patients":[8,43,60,94,144,227,243],"exhibiting":[9],"a":[10,38],"myelodepletive":[11,245],"phenotype":[12],"characterized":[13],"by":[14,73],"cytopenias":[15],"and":[16,57,83,107,110,133,172,208,219],"an":[17],"absent":[18,229],"or":[19,66,149,230],"low":[20,45,231],"JAK2V617F":[21,46,74,100,129,232],"allele":[22,47,75,101,117,130,146,176,233],"burden.":[23,48],"Ruxolitinib":[24],"may":[25,238],"be":[26,239],"less":[27],"effective":[28],"in":[29,41,85,134,203,226],"these":[30],"patients.":[31,119],"We":[32],"assessed":[33],"the":[34,55,160,174,204],"efficacy":[35],"of":[36,54,81,89],"pacritinib,":[37],"JAK2/IRAK1":[39],"inhibitor,":[40],"MF":[42,62],"In":[49],"this":[50],"post":[51],"hoc":[52],"analysis":[53],"PERSIST-1":[56],"-2":[58],"trials,":[59],"randomized":[63],"to":[64,206,210,216],"pacritinib":[65,161,200,237],"best":[67],"available":[68],"therapy":[69],"(BAT)":[70],"were":[71,95,125,140,194],"stratified":[72],"burden":[76,102,118,131,147,177,221],"quartile":[77],"for":[78,163,173,242],"spleen":[79,123,138,218],"response":[80,154],"\u226535%":[82],"improvement":[84],"total":[86],"symptom":[87,197,220],"score":[88],"\u226550%.":[90],"Five":[91],"hundred":[92],"thirty-six":[93],"included.":[96],"Patients":[97],"lower":[99,108],"had":[103],"smaller":[104],"baseline":[105],"spleens":[106],"hemoglobin":[109],"platelet":[111],"counts":[112],"as":[113],"compared":[114,223],"higher":[116,158],"Among":[120],"pacritinib-treated":[121],"patients,":[122],"responses":[124,139],"observed":[126,141],"across":[127],"all":[128],"quartiles":[132,178],"JAK2V617F-":[135,150,164],"disease.":[136,151],"No":[137],"among":[142],"BAT-treated":[143],"\u226450%":[148],"The":[152],"intention-to-treat":[153],"rate":[155],"was":[156],"significantly":[157,195],"on":[159],"arm":[162],"disease":[165],"(23.0%":[166],"vs":[167,181,188,201],"0%;":[168],"P":[169,183,190],"=":[170,191],".033),":[171],"lowest":[175],"(0%-25%:":[179],"20.9%":[180],"0%,":[182,189],"<":[184],".001;":[185],"25%-50%:":[186],"15.4%":[187],".020).":[192],"There":[193],"more":[196],"responders":[198],"BAT":[202,225],"0%":[205],"25%":[207,209],"50%":[211],"cohorts.":[212],"Pacritinib":[213],"treatment":[214],"led":[215],"superior":[217],"reduction":[222],"burden,":[234],"suggesting":[235],"that":[236],"uniquely":[240],"suited":[241],"MF.":[246]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-12-07T00:00:00"}